Renaissance Technologies - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 65 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q3 2020. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2022$183,000
+64.9%
57,500
+120.3%
0.00%
Q1 2022$111,000
-32.7%
26,100
-26.5%
0.00%
Q4 2021$165,000
-9.8%
35,500
-22.5%
0.00%
Q3 2021$183,000
+28.9%
45,836
+36.4%
0.00%
Q1 2021$142,000
-71.8%
33,600
-74.1%
0.00%
-100.0%
Q4 2020$504,000
+1020.0%
129,953
+1070.7%
0.00%
Q3 2020$45,000
-94.9%
11,100
-94.6%
0.00%
-100.0%
Q2 2020$876,000
+26.6%
205,733
+726.3%
0.00%
-50.0%
Q3 2015$692,000
+133.8%
24,898
-9.1%
0.00%
+100.0%
Q1 2014$296,00027,4000.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q3 2020
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,914,970$81,007,00029.87%
RTW INVESTMENTS, LP 1,080,331$30,022,0009.33%
Avoro Capital Advisors LLC 804,299$22,351,0005.81%
ACUTA CAPITAL PARTNERS, LLC 122,222$3,397,0001.97%
Broadfin Capital, LLC 1,095,373$30,440,0001.69%
Belmont Global Advisors, Inc. 35,000$973,0001.65%
P.A.W. CAPITAL CORP 48,000$1,334,0001.53%
Perceptive Advisors 1,309,030$36,378,0001.45%
Iguana Healthcare Management, LLC 125,000$3,474,0001.37%
EAM Investors, LLC 97,350$2,705,0000.43%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders